TBIO (OTC)
TELESIS BIO INC
$0.001000
+0.000000 (+0.00%)
Prev close: $0.001000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Ronald C. Renaud, Jr., MBA
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $2,823.92M
- Employees
- —
- P/E (TTM)
- 74.36
- P/B (TTM)
- 6.82
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $25.83M |
| Benefits Costs and Expenses | $26.75M |
| Cost Of Revenue | $14.54M |
| Costs And Expenses | $26.75M |
| Gross Profit | $11.29M |
| Operating Expenses | $13.06M |
| Operating Income/Loss | -$1.77M |
| Income/Loss From Continuing Operations After Tax | -$922.00K |
| Income/Loss From Continuing Operations Before Tax | -$922.00K |
| Net Income/Loss | -$922.00K |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$922.00K |
| Net Income/Loss Available To Common Stockholders, Basic | -$922.00K |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.45 |
| Diluted Earnings Per Share | -$0.45 |
| Basic Average Shares | 1,885,508 |
| Diluted Average Shares | 1,885,508 |
| Assets | $20.80M |
| Current Assets | $5.93M |
| Inventory | $870.00K |
| Other Current Assets | $5.06M |
| Noncurrent Assets | $14.87M |
| Fixed Assets | $735.00K |
| Intangible Assets | $10.68M |
| Other Non-current Assets | $3.45M |
| Liabilities | $6.64M |
| Current Liabilities | $3.81M |
| Accounts Payable | $1.36M |
| Wages | $1.10M |
| Other Current Liabilities | $1.35M |
| Noncurrent Liabilities | $2.83M |
| Equity | $14.17M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $14.17M |
| Liabilities And Equity | $20.80M |
| Net Cash Flow From Operating Activities | $793.00K |
| Net Cash Flow From Operating Activities, Continuing | $793.00K |
| Net Cash Flow From Investing Activities | -$238.00K |
| Net Cash Flow From Investing Activities, Continuing | -$238.00K |
| Net Cash Flow From Financing Activities | $1.03M |
| Net Cash Flow From Financing Activities, Continuing | $1.03M |
| Net Cash Flow | $1.59M |
| Net Cash Flow, Continuing | $1.59M |
| Comprehensive Income/Loss | -$922.00K |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$922.00K |
| Other Comprehensive Income/Loss | $0.00 |